United Therapeutics Prepaid & Other Current decreased by 8.4% to $228.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 73.9%, from $131.10M to $228.00M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows an upward trend with a 23.0% CAGR.
Significant fluctuations may indicate changes in corporate procurement cycles or shifts in accounting for short-term financial instruments.
Payments made in advance for services or goods to be received within the next year, alongside other miscellaneous short-...
Generally a small percentage of current assets; large spikes may warrant investigation into non-recurring items.
prepaid_and_other_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.10M | $76.00M | $100.40M | $60.20M | $165.80M | $118.10M | $219.20M | $92.60M | $158.40M | $220.50M | $166.20M | $113.40M | $220.80M | $185.40M | $169.70M | $131.10M | $229.70M | $252.20M | $248.90M | $228.00M |
| QoQ Change | — | -12.7% | +32.1% | -40.0% | +175.4% | -28.8% | +85.6% | -57.8% | +71.1% | +39.2% | -24.6% | -31.8% | +94.7% | -16.0% | -8.5% | -22.7% | +75.2% | +9.8% | -1.3% | -8.4% |
| YoY Change | — | — | — | — | +90.4% | +55.4% | +118.3% | +53.8% | -4.5% | +86.7% | -24.2% | +22.5% | +39.4% | -15.9% | +2.1% | +15.6% | +4.0% | +36.0% | +46.7% | +73.9% |